About Us Services Careers FAQ Contact Us 0
Home Technology Artificial Intelligence (AI) in Life Sciences Market Size, Share & Growth Report 2032
Artificial Intelligence (AI) in Life Sciences Market

Artificial Intelligence (AI) in Life Sciences Market Size, Share & Trends Analysis Report By Technology (Machine Learning (ML), Deep Learning (DL), Natural Language Processing (NLP), Others), By Application (Drug Discovery, Medical Diagnosis, Biotechnology, Clinical Trials, Precision and Personalized Medicine, Patient Monitoring, Novel Drug Candidates, Drug Optimization and Repurposing Preclinical Testing and Approval, Drug Monitoring, Finding New Diseases Associated Targets and Pathways, Understanding Disease Mechanisms, Aggregating and Synthesizing Information, Formation & Qualification of Hypotheses, De Novo Drug Design, Finding Drug Targets of an Old Drug), By Drug Type (Small Molecule, Large Molecule), By Offering (Software, Services), By Indication (Immuno-Oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Metabolic Diseases, Others), By End user (Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs), Research Centres And Academic Institutes, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRTE2445DR
Last Updated : October 27, 2023
Author : Straits Research
Starting From
USD 2300
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Artificial Intelligence (AI) in Life Sciences Market Introduction
    2. By Technology
      1. Introduction
        1. Technology By Value
      2. Machine Learning (ML)
        1. By Value
      3. Deep Learning (DL)
        1. By Value
      4. Natural Language Processing (NLP)
        1. By Value
      5. Others
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Drug Discovery
        1. By Value
      3. Medical Diagnosis
        1. By Value
      4. Biotechnology
        1. By Value
      5. Clinical Trials
        1. By Value
      6. Precision and Personalized Medicine
        1. By Value
      7. Patient Monitoring
        1. By Value
      8. Novel Drug Candidates
        1. By Value
      9. Drug Optimization and Repurposing Preclinical Testing and Approval
        1. By Value
      10. Drug Monitoring
        1. By Value
      11.  Finding New Diseases Associated Targets and Pathways
        1. By Value
      12.  Understanding Disease Mechanisms
        1. By Value
      13.  Aggregating and Synthesizing Information
        1. By Value
      14.  Formation & Qualification of Hypotheses
        1. By Value
      15.  De Novo Drug Design
        1. By Value
      16.  Finding Drug Targets of an Old Drug
        1. By Value
    4. By Drug Type
      1. Introduction
        1. Drug Type By Value
      2. Small Molecule
        1. By Value
      3. Large Molecule
        1. By Value
    5. By Offering
      1. Introduction
        1. Offering By Value
      2. Software
        1. By Value
      3. Services
        1. By Value
    6. By Indication
      1. Introduction
        1. Indication By Value
      2. Immuno-Oncology
        1. By Value
      3. Neurodegenerative Diseases
        1. By Value
      4. Cardiovascular Diseases
        1. By Value
      5. Metabolic Diseases
        1. By Value
      6. Others
        1. By Value
    7. By End user
      1. Introduction
        1. End user By Value
      2. Pharmaceutical & Biotechnology Companies
        1. By Value
      3. Contract Research Organizations (CROs)
        1. By Value
      4. Research Centres And Academic Institutes
        1. By Value
      5. Others
        1. By Value
    1. Introduction
    2. By Technology
      1. Introduction
        1. Technology By Value
      2. Machine Learning (ML)
        1. By Value
      3. Deep Learning (DL)
        1. By Value
      4. Natural Language Processing (NLP)
        1. By Value
      5. Others
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Drug Discovery
        1. By Value
      3. Medical Diagnosis
        1. By Value
      4. Biotechnology
        1. By Value
      5. Clinical Trials
        1. By Value
      6. Precision and Personalized Medicine
        1. By Value
      7. Patient Monitoring
        1. By Value
      8. Novel Drug Candidates
        1. By Value
      9. Drug Optimization and Repurposing Preclinical Testing and Approval
        1. By Value
      10. Drug Monitoring
        1. By Value
      11.  Finding New Diseases Associated Targets and Pathways
        1. By Value
      12.  Understanding Disease Mechanisms
        1. By Value
      13.  Aggregating and Synthesizing Information
        1. By Value
      14.  Formation & Qualification of Hypotheses
        1. By Value
      15.  De Novo Drug Design
        1. By Value
      16.  Finding Drug Targets of an Old Drug
        1. By Value
    4. By Drug Type
      1. Introduction
        1. Drug Type By Value
      2. Small Molecule
        1. By Value
      3. Large Molecule
        1. By Value
    5. By Offering
      1. Introduction
        1. Offering By Value
      2. Software
        1. By Value
      3. Services
        1. By Value
    6. By Indication
      1. Introduction
        1. Indication By Value
      2. Immuno-Oncology
        1. By Value
      3. Neurodegenerative Diseases
        1. By Value
      4. Cardiovascular Diseases
        1. By Value
      5. Metabolic Diseases
        1. By Value
      6. Others
        1. By Value
    7. By End user
      1. Introduction
        1. End user By Value
      2. Pharmaceutical & Biotechnology Companies
        1. By Value
      3. Contract Research Organizations (CROs)
        1. By Value
      4. Research Centres And Academic Institutes
        1. By Value
      5. Others
        1. By Value
    8. U.S.
      1. By Technology
        1. Introduction
          1. Technology By Value
        2. Machine Learning (ML)
          1. By Value
        3. Deep Learning (DL)
          1. By Value
        4. Natural Language Processing (NLP)
          1. By Value
        5. Others
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Drug Discovery
          1. By Value
        3. Medical Diagnosis
          1. By Value
        4. Biotechnology
          1. By Value
        5. Clinical Trials
          1. By Value
        6. Precision and Personalized Medicine
          1. By Value
        7. Patient Monitoring
          1. By Value
        8. Novel Drug Candidates
          1. By Value
        9. Drug Optimization and Repurposing Preclinical Testing and Approval
          1. By Value
        10. Drug Monitoring
          1. By Value
        11.  Finding New Diseases Associated Targets and Pathways
          1. By Value
        12.  Understanding Disease Mechanisms
          1. By Value
        13.  Aggregating and Synthesizing Information
          1. By Value
        14.  Formation & Qualification of Hypotheses
          1. By Value
        15.  De Novo Drug Design
          1. By Value
        16.  Finding Drug Targets of an Old Drug
          1. By Value
      3. By Drug Type
        1. Introduction
          1. Drug Type By Value
        2. Small Molecule
          1. By Value
        3. Large Molecule
          1. By Value
      4. By Offering
        1. Introduction
          1. Offering By Value
        2. Software
          1. By Value
        3. Services
          1. By Value
      5. By Indication
        1. Introduction
          1. Indication By Value
        2. Immuno-Oncology
          1. By Value
        3. Neurodegenerative Diseases
          1. By Value
        4. Cardiovascular Diseases
          1. By Value
        5. Metabolic Diseases
          1. By Value
        6. Others
          1. By Value
      6. By End user
        1. Introduction
          1. End user By Value
        2. Pharmaceutical & Biotechnology Companies
          1. By Value
        3. Contract Research Organizations (CROs)
          1. By Value
        4. Research Centres And Academic Institutes
          1. By Value
        5. Others
          1. By Value
    9. Canada
    1. Introduction
    2. By Technology
      1. Introduction
        1. Technology By Value
      2. Machine Learning (ML)
        1. By Value
      3. Deep Learning (DL)
        1. By Value
      4. Natural Language Processing (NLP)
        1. By Value
      5. Others
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Drug Discovery
        1. By Value
      3. Medical Diagnosis
        1. By Value
      4. Biotechnology
        1. By Value
      5. Clinical Trials
        1. By Value
      6. Precision and Personalized Medicine
        1. By Value
      7. Patient Monitoring
        1. By Value
      8. Novel Drug Candidates
        1. By Value
      9. Drug Optimization and Repurposing Preclinical Testing and Approval
        1. By Value
      10. Drug Monitoring
        1. By Value
      11.  Finding New Diseases Associated Targets and Pathways
        1. By Value
      12.  Understanding Disease Mechanisms
        1. By Value
      13.  Aggregating and Synthesizing Information
        1. By Value
      14.  Formation & Qualification of Hypotheses
        1. By Value
      15.  De Novo Drug Design
        1. By Value
      16.  Finding Drug Targets of an Old Drug
        1. By Value
    4. By Drug Type
      1. Introduction
        1. Drug Type By Value
      2. Small Molecule
        1. By Value
      3. Large Molecule
        1. By Value
    5. By Offering
      1. Introduction
        1. Offering By Value
      2. Software
        1. By Value
      3. Services
        1. By Value
    6. By Indication
      1. Introduction
        1. Indication By Value
      2. Immuno-Oncology
        1. By Value
      3. Neurodegenerative Diseases
        1. By Value
      4. Cardiovascular Diseases
        1. By Value
      5. Metabolic Diseases
        1. By Value
      6. Others
        1. By Value
    7. By End user
      1. Introduction
        1. End user By Value
      2. Pharmaceutical & Biotechnology Companies
        1. By Value
      3. Contract Research Organizations (CROs)
        1. By Value
      4. Research Centres And Academic Institutes
        1. By Value
      5. Others
        1. By Value
    8. U.K.
      1. By Technology
        1. Introduction
          1. Technology By Value
        2. Machine Learning (ML)
          1. By Value
        3. Deep Learning (DL)
          1. By Value
        4. Natural Language Processing (NLP)
          1. By Value
        5. Others
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Drug Discovery
          1. By Value
        3. Medical Diagnosis
          1. By Value
        4. Biotechnology
          1. By Value
        5. Clinical Trials
          1. By Value
        6. Precision and Personalized Medicine
          1. By Value
        7. Patient Monitoring
          1. By Value
        8. Novel Drug Candidates
          1. By Value
        9. Drug Optimization and Repurposing Preclinical Testing and Approval
          1. By Value
        10. Drug Monitoring
          1. By Value
        11.  Finding New Diseases Associated Targets and Pathways
          1. By Value
        12.  Understanding Disease Mechanisms
          1. By Value
        13.  Aggregating and Synthesizing Information
          1. By Value
        14.  Formation & Qualification of Hypotheses
          1. By Value
        15.  De Novo Drug Design
          1. By Value
        16.  Finding Drug Targets of an Old Drug
          1. By Value
      3. By Drug Type
        1. Introduction
          1. Drug Type By Value
        2. Small Molecule
          1. By Value
        3. Large Molecule
          1. By Value
      4. By Offering
        1. Introduction
          1. Offering By Value
        2. Software
          1. By Value
        3. Services
          1. By Value
      5. By Indication
        1. Introduction
          1. Indication By Value
        2. Immuno-Oncology
          1. By Value
        3. Neurodegenerative Diseases
          1. By Value
        4. Cardiovascular Diseases
          1. By Value
        5. Metabolic Diseases
          1. By Value
        6. Others
          1. By Value
      6. By End user
        1. Introduction
          1. End user By Value
        2. Pharmaceutical & Biotechnology Companies
          1. By Value
        3. Contract Research Organizations (CROs)
          1. By Value
        4. Research Centres And Academic Institutes
          1. By Value
        5. Others
          1. By Value
    9. Germany
    10. France
    11. Spain
    12. Italy
    13. Russia
    14. Nordic
    15. Benelux
    16. Rest of Europe
    1. Introduction
    2. By Technology
      1. Introduction
        1. Technology By Value
      2. Machine Learning (ML)
        1. By Value
      3. Deep Learning (DL)
        1. By Value
      4. Natural Language Processing (NLP)
        1. By Value
      5. Others
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Drug Discovery
        1. By Value
      3. Medical Diagnosis
        1. By Value
      4. Biotechnology
        1. By Value
      5. Clinical Trials
        1. By Value
      6. Precision and Personalized Medicine
        1. By Value
      7. Patient Monitoring
        1. By Value
      8. Novel Drug Candidates
        1. By Value
      9. Drug Optimization and Repurposing Preclinical Testing and Approval
        1. By Value
      10. Drug Monitoring
        1. By Value
      11.  Finding New Diseases Associated Targets and Pathways
        1. By Value
      12.  Understanding Disease Mechanisms
        1. By Value
      13.  Aggregating and Synthesizing Information
        1. By Value
      14.  Formation & Qualification of Hypotheses
        1. By Value
      15.  De Novo Drug Design
        1. By Value
      16.  Finding Drug Targets of an Old Drug
        1. By Value
    4. By Drug Type
      1. Introduction
        1. Drug Type By Value
      2. Small Molecule
        1. By Value
      3. Large Molecule
        1. By Value
    5. By Offering
      1. Introduction
        1. Offering By Value
      2. Software
        1. By Value
      3. Services
        1. By Value
    6. By Indication
      1. Introduction
        1. Indication By Value
      2. Immuno-Oncology
        1. By Value
      3. Neurodegenerative Diseases
        1. By Value
      4. Cardiovascular Diseases
        1. By Value
      5. Metabolic Diseases
        1. By Value
      6. Others
        1. By Value
    7. By End user
      1. Introduction
        1. End user By Value
      2. Pharmaceutical & Biotechnology Companies
        1. By Value
      3. Contract Research Organizations (CROs)
        1. By Value
      4. Research Centres And Academic Institutes
        1. By Value
      5. Others
        1. By Value
    8. China
      1. By Technology
        1. Introduction
          1. Technology By Value
        2. Machine Learning (ML)
          1. By Value
        3. Deep Learning (DL)
          1. By Value
        4. Natural Language Processing (NLP)
          1. By Value
        5. Others
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Drug Discovery
          1. By Value
        3. Medical Diagnosis
          1. By Value
        4. Biotechnology
          1. By Value
        5. Clinical Trials
          1. By Value
        6. Precision and Personalized Medicine
          1. By Value
        7. Patient Monitoring
          1. By Value
        8. Novel Drug Candidates
          1. By Value
        9. Drug Optimization and Repurposing Preclinical Testing and Approval
          1. By Value
        10. Drug Monitoring
          1. By Value
        11.  Finding New Diseases Associated Targets and Pathways
          1. By Value
        12.  Understanding Disease Mechanisms
          1. By Value
        13.  Aggregating and Synthesizing Information
          1. By Value
        14.  Formation & Qualification of Hypotheses
          1. By Value
        15.  De Novo Drug Design
          1. By Value
        16.  Finding Drug Targets of an Old Drug
          1. By Value
      3. By Drug Type
        1. Introduction
          1. Drug Type By Value
        2. Small Molecule
          1. By Value
        3. Large Molecule
          1. By Value
      4. By Offering
        1. Introduction
          1. Offering By Value
        2. Software
          1. By Value
        3. Services
          1. By Value
      5. By Indication
        1. Introduction
          1. Indication By Value
        2. Immuno-Oncology
          1. By Value
        3. Neurodegenerative Diseases
          1. By Value
        4. Cardiovascular Diseases
          1. By Value
        5. Metabolic Diseases
          1. By Value
        6. Others
          1. By Value
      6. By End user
        1. Introduction
          1. End user By Value
        2. Pharmaceutical & Biotechnology Companies
          1. By Value
        3. Contract Research Organizations (CROs)
          1. By Value
        4. Research Centres And Academic Institutes
          1. By Value
        5. Others
          1. By Value
    9. Korea
    10. Japan
    11. India
    12. Australia
    13. Taiwan
    14. South East Asia
    15. Rest of Asia-Pacific
    1. Introduction
    2. By Technology
      1. Introduction
        1. Technology By Value
      2. Machine Learning (ML)
        1. By Value
      3. Deep Learning (DL)
        1. By Value
      4. Natural Language Processing (NLP)
        1. By Value
      5. Others
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Drug Discovery
        1. By Value
      3. Medical Diagnosis
        1. By Value
      4. Biotechnology
        1. By Value
      5. Clinical Trials
        1. By Value
      6. Precision and Personalized Medicine
        1. By Value
      7. Patient Monitoring
        1. By Value
      8. Novel Drug Candidates
        1. By Value
      9. Drug Optimization and Repurposing Preclinical Testing and Approval
        1. By Value
      10. Drug Monitoring
        1. By Value
      11.  Finding New Diseases Associated Targets and Pathways
        1. By Value
      12.  Understanding Disease Mechanisms
        1. By Value
      13.  Aggregating and Synthesizing Information
        1. By Value
      14.  Formation & Qualification of Hypotheses
        1. By Value
      15.  De Novo Drug Design
        1. By Value
      16.  Finding Drug Targets of an Old Drug
        1. By Value
    4. By Drug Type
      1. Introduction
        1. Drug Type By Value
      2. Small Molecule
        1. By Value
      3. Large Molecule
        1. By Value
    5. By Offering
      1. Introduction
        1. Offering By Value
      2. Software
        1. By Value
      3. Services
        1. By Value
    6. By Indication
      1. Introduction
        1. Indication By Value
      2. Immuno-Oncology
        1. By Value
      3. Neurodegenerative Diseases
        1. By Value
      4. Cardiovascular Diseases
        1. By Value
      5. Metabolic Diseases
        1. By Value
      6. Others
        1. By Value
    7. By End user
      1. Introduction
        1. End user By Value
      2. Pharmaceutical & Biotechnology Companies
        1. By Value
      3. Contract Research Organizations (CROs)
        1. By Value
      4. Research Centres And Academic Institutes
        1. By Value
      5. Others
        1. By Value
    8. UAE
      1. By Technology
        1. Introduction
          1. Technology By Value
        2. Machine Learning (ML)
          1. By Value
        3. Deep Learning (DL)
          1. By Value
        4. Natural Language Processing (NLP)
          1. By Value
        5. Others
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Drug Discovery
          1. By Value
        3. Medical Diagnosis
          1. By Value
        4. Biotechnology
          1. By Value
        5. Clinical Trials
          1. By Value
        6. Precision and Personalized Medicine
          1. By Value
        7. Patient Monitoring
          1. By Value
        8. Novel Drug Candidates
          1. By Value
        9. Drug Optimization and Repurposing Preclinical Testing and Approval
          1. By Value
        10. Drug Monitoring
          1. By Value
        11.  Finding New Diseases Associated Targets and Pathways
          1. By Value
        12.  Understanding Disease Mechanisms
          1. By Value
        13.  Aggregating and Synthesizing Information
          1. By Value
        14.  Formation & Qualification of Hypotheses
          1. By Value
        15.  De Novo Drug Design
          1. By Value
        16.  Finding Drug Targets of an Old Drug
          1. By Value
      3. By Drug Type
        1. Introduction
          1. Drug Type By Value
        2. Small Molecule
          1. By Value
        3. Large Molecule
          1. By Value
      4. By Offering
        1. Introduction
          1. Offering By Value
        2. Software
          1. By Value
        3. Services
          1. By Value
      5. By Indication
        1. Introduction
          1. Indication By Value
        2. Immuno-Oncology
          1. By Value
        3. Neurodegenerative Diseases
          1. By Value
        4. Cardiovascular Diseases
          1. By Value
        5. Metabolic Diseases
          1. By Value
        6. Others
          1. By Value
      6. By End user
        1. Introduction
          1. End user By Value
        2. Pharmaceutical & Biotechnology Companies
          1. By Value
        3. Contract Research Organizations (CROs)
          1. By Value
        4. Research Centres And Academic Institutes
          1. By Value
        5. Others
          1. By Value
    9. Turkey
    10. Saudi Arabia
    11. South Africa
    12. Egypt
    13. Nigeria
    14. Rest of MEA
    1. Introduction
    2. By Technology
      1. Introduction
        1. Technology By Value
      2. Machine Learning (ML)
        1. By Value
      3. Deep Learning (DL)
        1. By Value
      4. Natural Language Processing (NLP)
        1. By Value
      5. Others
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Drug Discovery
        1. By Value
      3. Medical Diagnosis
        1. By Value
      4. Biotechnology
        1. By Value
      5. Clinical Trials
        1. By Value
      6. Precision and Personalized Medicine
        1. By Value
      7. Patient Monitoring
        1. By Value
      8. Novel Drug Candidates
        1. By Value
      9. Drug Optimization and Repurposing Preclinical Testing and Approval
        1. By Value
      10. Drug Monitoring
        1. By Value
      11.  Finding New Diseases Associated Targets and Pathways
        1. By Value
      12.  Understanding Disease Mechanisms
        1. By Value
      13.  Aggregating and Synthesizing Information
        1. By Value
      14.  Formation & Qualification of Hypotheses
        1. By Value
      15.  De Novo Drug Design
        1. By Value
      16.  Finding Drug Targets of an Old Drug
        1. By Value
    4. By Drug Type
      1. Introduction
        1. Drug Type By Value
      2. Small Molecule
        1. By Value
      3. Large Molecule
        1. By Value
    5. By Offering
      1. Introduction
        1. Offering By Value
      2. Software
        1. By Value
      3. Services
        1. By Value
    6. By Indication
      1. Introduction
        1. Indication By Value
      2. Immuno-Oncology
        1. By Value
      3. Neurodegenerative Diseases
        1. By Value
      4. Cardiovascular Diseases
        1. By Value
      5. Metabolic Diseases
        1. By Value
      6. Others
        1. By Value
    7. By End user
      1. Introduction
        1. End user By Value
      2. Pharmaceutical & Biotechnology Companies
        1. By Value
      3. Contract Research Organizations (CROs)
        1. By Value
      4. Research Centres And Academic Institutes
        1. By Value
      5. Others
        1. By Value
    8. Brazil
      1. By Technology
        1. Introduction
          1. Technology By Value
        2. Machine Learning (ML)
          1. By Value
        3. Deep Learning (DL)
          1. By Value
        4. Natural Language Processing (NLP)
          1. By Value
        5. Others
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Drug Discovery
          1. By Value
        3. Medical Diagnosis
          1. By Value
        4. Biotechnology
          1. By Value
        5. Clinical Trials
          1. By Value
        6. Precision and Personalized Medicine
          1. By Value
        7. Patient Monitoring
          1. By Value
        8. Novel Drug Candidates
          1. By Value
        9. Drug Optimization and Repurposing Preclinical Testing and Approval
          1. By Value
        10. Drug Monitoring
          1. By Value
        11.  Finding New Diseases Associated Targets and Pathways
          1. By Value
        12.  Understanding Disease Mechanisms
          1. By Value
        13.  Aggregating and Synthesizing Information
          1. By Value
        14.  Formation & Qualification of Hypotheses
          1. By Value
        15.  De Novo Drug Design
          1. By Value
        16.  Finding Drug Targets of an Old Drug
          1. By Value
      3. By Drug Type
        1. Introduction
          1. Drug Type By Value
        2. Small Molecule
          1. By Value
        3. Large Molecule
          1. By Value
      4. By Offering
        1. Introduction
          1. Offering By Value
        2. Software
          1. By Value
        3. Services
          1. By Value
      5. By Indication
        1. Introduction
          1. Indication By Value
        2. Immuno-Oncology
          1. By Value
        3. Neurodegenerative Diseases
          1. By Value
        4. Cardiovascular Diseases
          1. By Value
        5. Metabolic Diseases
          1. By Value
        6. Others
          1. By Value
      6. By End user
        1. Introduction
          1. End user By Value
        2. Pharmaceutical & Biotechnology Companies
          1. By Value
        3. Contract Research Organizations (CROs)
          1. By Value
        4. Research Centres And Academic Institutes
          1. By Value
        5. Others
          1. By Value
    9. Mexico
    10. Argentina
    11. Chile
    12. Colombia
    13. Rest of LATAM
    1. Artificial Intelligence (AI) in Life Sciences Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. NuMedii Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Atomwise Inc.
    3. IBM Corporation
    4. AiCure LLC
    5. Nuance Communications Inc.
    6. Sensely Inc.
    7. Sophia Genetics SA
    8. Insilico Medicine Inc.
    9. Enlitic Inc.
    10. Apixio Inc.
    11. Zebra Medical Vision
    12. twoXAR Inc.
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Artificial Intelligence Chipsets Market Size The global artificial intelligence chipsets market size was valued at USD 34.82 billion in 2024 and is expected to grow from USD 47.10 billion by 2025 to reach USD 610.41 billion
Buy Now
Global Report
Artificial Intelligence in IoT Market Size The global artificial intelligence in IoT market size was valued at USD 9.25 billion in 2024 and is expected to grow from USD 11.08 billion in 2025 to reach USD 47.78 billion by 2033, growing at a CAGR of 1
Buy Now
Global Report
Artificial Intelligence in Oil and Gas Market Size The global artificial intelligence in oil and gas market size was valued at USD 16.22 billion in 2024 and is projected to reach from 18.32 billion in 2025 to USD 48.72 billion by 2033, growing at a
Buy Now
Global Report
Artificial Intelligence in Retail Market Size The global artificial intelligence in retail market size was valued at USD 5.43 billion in 2024 and is projected to reach from USD 7.12 billion in 2025 to USD 41.23 billion by 2033, exhibi
Buy Now
Global Report
Artificial Intelligence (AI) Market Size The global artificial intelligence (AI) market size was valued at USD 239.41 billion in 2024 and is expected to grow from USD 328.47 billion in 2025 to reach USD 4,124.10 bi
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.